The transition to value-based care allows clinicians to focus on a few common areas instead of multiple measures for different payers, explained Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS.
The transition to value-based care allows clinicians to focus on a few common areas instead of multiple measures for different payers, explained Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS.
Transcript (slightly modified)
CMS, AHIP, and other organizations have announced 7 core sets of quality measures. How does the implementation of these core sets of quality measures help the transition to value-based payments?
The transition to value-based care isn’t just happening from CMS alone. Commercial payers are also transitioning to value-based care. Think about it, if you’re a doctor in a practice, small or large, and you have a contract with five or seven different payers in your market, plus you see Medicare patients and you see Medicaid patients, you may be responding to multiple different sets of quality measures that aren’t aligned, and think about the burden that puts on you to have to do that.
So if we can get the quality measures for, let’s just say a primary care physician, or an oncologist, aligned across payers, they are responding to all of the same incentives for where they need to improve the quality of care they deliver. That is much more likely to actually lead to improvement in care for those patients, because physicians, anybody, can’t focus on 30 different areas to improve. And if you’re reporting on 30 different measures for five or seven different payers, there’s no way you can actually truly improve in any one area.
But if we can narrow that to a few common areas that are most important for patients and most relevant for doctors, the chances that you actually can significantly improve care for patients goes up dramatically. That is what the transition to value-based care is all about. It’s all about improving outcomes for patients in a more efficient manner, and improving the patient experience. The payers just have to be aligned in those incentives in order for this to be successful.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More